Articles

Apoptosis reprogramming triggered by splicing inhibitors sensitizes multiple myeloma cells to Venetoclax treatment

Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Italy
Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Italy; IRCCS Ospedale Policlinico San Martino, Clinic of Haematology, Genoa, Italy
Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Italy; IRCCS Ospedale Policlinico San Martino, Clinic of Haematology, Genoa, Italy
Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Italy
Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Italy
Hematology, Fondazione Cà Granda IRCCS Policlinico, Milan, Italy
IRCCS Ospedale Policlinico San Martino, Clinic of Haematology, Genoa, Italy; Department of Integrated Surgical and Diagnostic Sciences, University of Genoa, Italy
Department of Internal Medicine (DiMI), University of Genoa, Italy
IRCCS Ospedale Policlinico San Martino, Clinic of Haematology, Genoa, Italy
Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Italy; IRCCS Ospedale Policlinico San Martino, Clinic of Haematology, Genoa, Italy
Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Italy; IRCCS Ospedale Policlinico San Martino, Clinic of Haematology, Genoa, Italy
IRCCS Ospedale Policlinico San Martino, Clinic of Haematology, Genoa, Italy
Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Italy; IRCCS Ospedale Policlinico San Martino, Clinic of Haematology, Genoa, Italy
Hematology and Hematopoietic Stem Cell Transplantation Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy
Hematology and Hematopoietic Stem Cell Transplantation Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy
U.O. Molecular Pathology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy
IRCCS Ospedale Policlinico San Martino, Clinic of Haematology, Genoa, Italy; Department of Surgical Sciences and Integrated Diagnostic (DISC), University of Genoa, Italy
Department of Experimental Medicine, University of Genoa, Italy
IRCCS Ospedale Policlinico San Martino, Clinic of Haematology, Genoa, Italy; Department of Internal Medicine (DiMI), University of Genoa, Italy
Hematology, Fondazione Cà Granda IRCCS Policlinico, Milan, Italy; Department of Oncology and Haemato-oncology, University of Milan, Milan, Italy.
Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts
Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts
Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts
Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Italy; IRCCS Ospedale Policlinico San Martino, Clinic of Haematology, Genoa, Italy
Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Italy; IRCCS Ospedale Policlinico San Martino, Clinic of Haematology, Genoa, Italy
Haematologica Early view Oct 21, 2021 https://doi.org/10.3324/haematol.2021.279276